neutralizing antibodies for anti-monkeypox drug development

Creative Biolabs has been engaged in the antibody industry for more than ten years, offering a complete spectrum of monoclonal antibody antiviral drug development solutions. In the near future, the development of potential therapeutic approaches based on neutralizing antibodies against monkeypox could be effective in controlling the spread and infection of the monkeypox virus.